Proteomics: Unraveling the complexity of heart disease and striving to change cardiology

Current Opinion in Molecular Therapeutics

Volumn 3, Issue 6, 2001, Pages 546-553

  Van Eyk, J E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Biomarker; Cardiovascular disease; Myocardium; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; ELONGATION FACTOR TU; MESSENGER RNA; MYOSIN LIGHT CHAIN; PROTEIN KINASE C; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CARDIOLOGY; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION REGULATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS; RAT; RNA SPLICING; STAGING; STUNNED HEART MUSCLE;

CARDIOLOGY; HEART DISEASES; HUMANS; PROTEOME;

ANIMALIA;

EID: 0035672575     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Proteomics in human disease: Cancer, heart and infectious diseases
2. Studying heart disease using the proteomic approach
3. Proteomics: New perspectives, new biomedical opportunities
4. Cardiovascular proteomics: Evolution and potential
5. Application of proteomics to the study of cardiovascular biology
6. Mechanisms of postischemic contractile dysfunction
7. Molecular and cellular mechanisms of myocardial stunning
8. The role of troponin abnormalities as a definitive cause for stunned myocardium
9. Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
10. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction
11. Pathophysiology of chronic heart failure
12. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1
13. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection
14. Phosphorylation of mitochondrial elongation factor Tu in ischemic myocardium: Basis for chloramphenicol-mediated cardioprotection
15. Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: Surfactant effects on membrane solubilization
16. The current state of twodimensional electrophoresis with immobilized pH gradients
17. A combined radiolabeling and silver staining technique for improved visualization, localization and identification of proteins separated by two-dimensional gel electrophoresis
18. Proteomics to study genes and genomes
19. Mass spectrometry. From genomics to proteomics
20. Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis
21. Proteomic strategies for biomarker identification: Progress and challenges
22. Reverse phase protein microarrays with capture disease progression show activation of pro-survival pathways at the cancer invasion front
23. Protein quantification from complex protein mixtures using a proteomic methodology with single cell resolution
24. A two-dimensional electrophoresis database of rat heart proteins
25. Construction of HSC-2D PAGE: A two dimensional gel electrophoresis database of heart proteins
26. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis
27. Coelectrophoresis of cardiac tissue from human, dog, rat and mouse: Towards the establishment of an integrated two-dimensional protein database
28. Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry
29. An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy
30. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis
31. Changes in myocardial protein expression in pacing-induced canine heart failure
32. Bovine dilated cardiomyopathy: Proteomic analysis of an animal model of human dilated cardiomyopathy
33. Effects of calcium, Inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts
34. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy
35. Cardiac troponin I is modified in the myocardium of bypass patients
36. Identification and characterization of heat shock protein 27 protein species in human myocardial two-dimensional electrophoresis patterns
37. Zooming-in on the proteome: Very narrow-range immobilized pH gradients reveal more protein species and isoforms
38. Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: The signaling module hypothesis
39. Genomic circuits and integrative biology of cardiac disease
40. Genomics and the pathophysiology of heart failure
41. Gene expression analysis by transcript profiling coupled to a gene data base query
42. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury
43. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy
44. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags
45. Altered pattern of gene expression in response to myocardial infarction
46. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs
47. Prepare to meet your markers: Making the most out of troponin I degradation
48. Cardiac troponins: Exploiting the diagnostic potential of disease-induced protein modifications
49. Transgenic mouse model of stunned myocardium